id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-4845-0701,FDA,FDA-2018-N-4845,Letter to College Pharmacy from FDA CDER,Other,Letter(s),2019-12-05T05:00:00Z,2019,12,2019-12-05T05:00:00Z,,2019-12-05T15:40:49Z,,0,0,09000064841e81ef
FDA-2018-N-4845-0001,FDA,FDA-2018-N-4845,"Amendments to the List of Bulk Drug Substances That Can Be Used to
Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-09-05T04:00:00Z,2019,9,2019-09-05T04:00:00Z,2019-12-05T04:59:59Z,2019-12-06T02:01:33Z,2019-18951,0,0,0900006483eed96e